Cargando...

Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 M(Pro) Inhibitor

The COVID-19 pandemic is still active around the globe despite the newly introduced vaccines. Hence, finding effective medications or repurposing available ones could offer great help during this serious situation. During our anti-COVID-19 investigation of microbial natural products (MNPs), we came...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmaceuticals (Basel)
Main Authors: Alhadrami, Hani A., Sayed, Ahmed M., Al-Khatabi, Heba, Alhakamy, Nabil A., Rateb, Mostafa E.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8229550/
https://ncbi.nlm.nih.gov/pubmed/34198933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14060541
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!